RxDoctor Payments Data

Tyler Bliss, MD

Otolaryngology · Omaha, NENPI 1063894913

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (58.5%), food and beverage and education — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Medical Device Business Services, Inc. at 46.6% of the total. Reporting peaked in 2019 at $2,520 and has fallen 86.5% since, to $340 in 2025. Among otolaryngology clinicians in NE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,684in general payments, 2019–2025

Across 65 payments — averaging $56.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$2K
  • Stryker$642
  • Smith+Nephew$245
  • Acclarent, Inc$235
  • Aerin Medical Inc.$211
  • Optinose US, Inc.$87
  • plus $546 from 17 others

What the payments were for

  • Travel & lodging$2,15659%
  • Food & beverage$1,32436%
  • Education$1765%
  • Other$291%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,684 in reported general payments places this provider in the 90th percentile of 86 otolaryngology providers in Nebraska.

See all otolaryngology providers in Nebraska

Medicare billing

Part B allowed, 2024
$126,881
Medicare patients
369
Services billed
1,214

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide75$2,692
Fluticasone Propionate138$2,122
Montelukast Sodium31$550
Lidocaine Hcl ViscousLidocaine Hcl24$546
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav41$544
Pantoprazole Sodium36$516
Levothyroxine Sodium53$454
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha37$434
Mupirocin38$278
Gabapentin30$274
Omeprazole12$242
Liothyronine Sodium15$171
Methimazole12$136
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen18$135
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim16$108

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →